BRIUMVI-ONE Trademark

Trademark Overview


On Friday, May 22, 2026, a trademark application was filed for BRIUMVI-ONE with the United States Patent and Trademark Office. The USPTO has given the BRIUMVI-ONE trademark a serial number of 99840452. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, May 22, 2026. This trademark is owned by TG Therapeutics, Inc.. The BRIUMVI-ONE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use, namely, pharmaceutical preparations for the prevention and treatment of multiple sclerosis

General Information


Serial Number99840452
Word MarkBRIUMVI-ONE
Filing DateFriday, May 22, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateFriday, May 22, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkBRIUMVI ONE
Goods and ServicesPharmaceutical preparations for human use, namely, pharmaceutical preparations for the prevention and treatment of multiple sclerosis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 22, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTG Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10014
US

Trademark Events


Event DateEvent Description
Friday, May 22, 2026NEW APPLICATION ENTERED
Friday, May 22, 2026APPLICATION FILING RECEIPT MAILED